Addiction & Substance Use

How can telehealth aid in the treatment of opioid use disorders in this patient population?

Take a look back at our recent coverage relating to our April content theme.

What is new in research on alcohol use disorder?

In honor of this year’s National Alcohol Screening Day, here’s a look back at some recent coverage in Psychiatric Times about the diagnosis, treatment, and management of alcohol misuse.

Write to us now to be part of our series focused on addiction and substance use disorders this month.

What is new in research on COVID-19?

What is new in research on child and adolescent psychiatry?

The experts weighed in on a wide variety of psychiatric issues for the February 2024 issue of Psychiatric Times.

Here are some updates from the world of psychiatry throughout the month of February.

Psychiatric Times® Substance Use Section Editor Roueen Rafeyan, MD, DFAPA, FASAM, weighs in.

Problematic gaming is challenging to treat. Here's how you can get started.

From pain and suicidality in patients with depression to digital mental health interventions for adolescents with eating disorders, here are highlights from the week in Psychiatric Times.

The grant programs are aimed at supporting treatment services for pregnant and postpartum individuals and individuals involved in treatment drug courts.

The experts weighed in on a wide variety of psychiatric issues for the January 2024 issue of Psychiatric Times.

From noninvasive brain stimulation for substance use disorders to updates from APSARD 2024, here are highlights from the week in Psychiatric Times.

In this CME article, review the current treatment modalities for noninvasive brain stimulation in the treatment of substance use disorders, and to explore the potential for further expansion of indications.

This APSARD 2024 conference poster finds that individuals with ADHD have distinct motivations and patterns of substance use.

Regular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.

From substance use disorders in physicians to new research on the efficacy of MDMA-assisted therapy for PTSD, here are highlights from the week in Psychiatric Times.

What is new in research on posttraumatic stress disorder?

Captagon tablets: how are they impacting the current state of world affairs?

Reviewing a year of CMEs in Psychiatric Times®

What is new in research on cannabis?

What neuromodulation can be used to specifically target nicotine users with schizophrenia? This research may tell us.